img

Global Antimicrobial Peptides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antimicrobial Peptides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
Antimicrobial Peptides report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antimicrobial Peptides market is projected to reach US$ 7 million in 2034, increasing from US$ 5 million in 2022, with the CAGR of 5.4% during the period of 2024 to 2034. Demand from Pharmaceuticals and Feed Additives are the major drivers for the industry.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antimicrobial Peptides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
Segment by Type
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides

Segment by Application


Pharmaceuticals
Feed Additives
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antimicrobial Peptides market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antimicrobial Peptides, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antimicrobial Peptides industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antimicrobial Peptides in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antimicrobial Peptides introduction, etc. Antimicrobial Peptides Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Antimicrobial Peptides market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Antimicrobial Peptides Market Overview
1.1 Antimicrobial Peptides Product Overview
1.2 Antimicrobial Peptides Market Segment by Type
1.2.1 Plant Antimicrobial Peptides
1.2.2 Microbial Antimicrobial Peptides
1.2.3 Animal Antimicrobial Peptides
1.3 Global Antimicrobial Peptides Market Size by Type
1.3.1 Global Antimicrobial Peptides Market Size Overview by Type (2018-2034)
1.3.2 Global Antimicrobial Peptides Historic Market Size Review by Type (2018-2024)
1.3.3 Global Antimicrobial Peptides Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antimicrobial Peptides Sales Breakdown by Type (2018-2024)
1.4.2 Europe Antimicrobial Peptides Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Antimicrobial Peptides Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Antimicrobial Peptides Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Antimicrobial Peptides Sales Breakdown by Type (2018-2024)
2 Global Antimicrobial Peptides Market Competition by Company
2.1 Global Top Players by Antimicrobial Peptides Sales (2018-2024)
2.2 Global Top Players by Antimicrobial Peptides Revenue (2018-2024)
2.3 Global Top Players by Antimicrobial Peptides Price (2018-2024)
2.4 Global Top Manufacturers Antimicrobial Peptides Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antimicrobial Peptides Market Competitive Situation and Trends
2.5.1 Antimicrobial Peptides Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Antimicrobial Peptides Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2022)
2.7 Date of Key Manufacturers Enter into Antimicrobial Peptides Market
2.8 Key Manufacturers Antimicrobial Peptides Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antimicrobial Peptides Status and Outlook by Region
3.1 Global Antimicrobial Peptides Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Antimicrobial Peptides Historic Market Size by Region
3.2.1 Global Antimicrobial Peptides Sales in Volume by Region (2018-2024)
3.2.2 Global Antimicrobial Peptides Sales in Value by Region (2018-2024)
3.2.3 Global Antimicrobial Peptides Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Antimicrobial Peptides Forecasted Market Size by Region
3.3.1 Global Antimicrobial Peptides Sales in Volume by Region (2024-2034)
3.3.2 Global Antimicrobial Peptides Sales in Value by Region (2024-2034)
3.3.3 Global Antimicrobial Peptides Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Antimicrobial Peptides by Application
4.1 Antimicrobial Peptides Market Segment by Application
4.1.1 Pharmaceuticals
4.1.2 Feed Additives
4.1.3 Others
4.2 Global Antimicrobial Peptides Market Size by Application
4.2.1 Global Antimicrobial Peptides Market Size Overview by Application (2018-2034)
4.2.2 Global Antimicrobial Peptides Historic Market Size Review by Application (2018-2024)
4.2.3 Global Antimicrobial Peptides Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antimicrobial Peptides Sales Breakdown by Application (2018-2024)
4.3.2 Europe Antimicrobial Peptides Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Antimicrobial Peptides Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Antimicrobial Peptides Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Antimicrobial Peptides Sales Breakdown by Application (2018-2024)
5 North America Antimicrobial Peptides by Country
5.1 North America Antimicrobial Peptides Historic Market Size by Country
5.1.1 North America Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Antimicrobial Peptides Sales in Volume by Country (2018-2024)
5.1.3 North America Antimicrobial Peptides Sales in Value by Country (2018-2024)
5.2 North America Antimicrobial Peptides Forecasted Market Size by Country
5.2.1 North America Antimicrobial Peptides Sales in Volume by Country (2024-2034)
5.2.2 North America Antimicrobial Peptides Sales in Value by Country (2024-2034)
6 Europe Antimicrobial Peptides by Country
6.1 Europe Antimicrobial Peptides Historic Market Size by Country
6.1.1 Europe Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Antimicrobial Peptides Sales in Volume by Country (2018-2024)
6.1.3 Europe Antimicrobial Peptides Sales in Value by Country (2018-2024)
6.2 Europe Antimicrobial Peptides Forecasted Market Size by Country
6.2.1 Europe Antimicrobial Peptides Sales in Volume by Country (2024-2034)
6.2.2 Europe Antimicrobial Peptides Sales in Value by Country (2024-2034)
7 Asia-Pacific Antimicrobial Peptides by Region
7.1 Asia-Pacific Antimicrobial Peptides Historic Market Size by Region
7.1.1 Asia-Pacific Antimicrobial Peptides Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Antimicrobial Peptides Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Antimicrobial Peptides Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Antimicrobial Peptides Forecasted Market Size by Region
7.2.1 Asia-Pacific Antimicrobial Peptides Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Antimicrobial Peptides Sales in Value by Region (2024-2034)
8 Latin America Antimicrobial Peptides by Country
8.1 Latin America Antimicrobial Peptides Historic Market Size by Country
8.1.1 Latin America Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Antimicrobial Peptides Sales in Volume by Country (2018-2024)
8.1.3 Latin America Antimicrobial Peptides Sales in Value by Country (2018-2024)
8.2 Latin America Antimicrobial Peptides Forecasted Market Size by Country
8.2.1 Latin America Antimicrobial Peptides Sales in Volume by Country (2024-2034)
8.2.2 Latin America Antimicrobial Peptides Sales in Value by Country (2024-2034)
9 Middle East and Africa Antimicrobial Peptides by Country
9.1 Middle East and Africa Antimicrobial Peptides Historic Market Size by Country
9.1.1 Middle East and Africa Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Antimicrobial Peptides Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Antimicrobial Peptides Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Antimicrobial Peptides Forecasted Market Size by Country
9.2.1 Middle East and Africa Antimicrobial Peptides Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Antimicrobial Peptides Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AnaSpec
10.1.1 AnaSpec Company Information
10.1.2 AnaSpec Introduction and Business Overview
10.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AnaSpec Antimicrobial Peptides Products Offered
10.1.5 AnaSpec Recent Development
10.2 AMP Biotech
10.2.1 AMP Biotech Company Information
10.2.2 AMP Biotech Introduction and Business Overview
10.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AMP Biotech Antimicrobial Peptides Products Offered
10.2.5 AMP Biotech Recent Development
10.3 Phoenix Biotech
10.3.1 Phoenix Biotech Company Information
10.3.2 Phoenix Biotech Introduction and Business Overview
10.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Phoenix Biotech Antimicrobial Peptides Products Offered
10.3.5 Phoenix Biotech Recent Development
10.4 Novabiotics
10.4.1 Novabiotics Company Information
10.4.2 Novabiotics Introduction and Business Overview
10.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Novabiotics Antimicrobial Peptides Products Offered
10.4.5 Novabiotics Recent Development
10.5 Chinese Peptide
10.5.1 Chinese Peptide Company Information
10.5.2 Chinese Peptide Introduction and Business Overview
10.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Chinese Peptide Antimicrobial Peptides Products Offered
10.5.5 Chinese Peptide Recent Development
10.6 Ontores
10.6.1 Ontores Company Information
10.6.2 Ontores Introduction and Business Overview
10.6.3 Ontores Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Ontores Antimicrobial Peptides Products Offered
10.6.5 Ontores Recent Development
10.7 GenScript
10.7.1 GenScript Company Information
10.7.2 GenScript Introduction and Business Overview
10.7.3 GenScript Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2024)
10.7.4 GenScript Antimicrobial Peptides Products Offered
10.7.5 GenScript Recent Development
10.8 Hycult Biotech
10.8.1 Hycult Biotech Company Information
10.8.2 Hycult Biotech Introduction and Business Overview
10.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Hycult Biotech Antimicrobial Peptides Products Offered
10.8.5 Hycult Biotech Recent Development
10.9 Sunsmile
10.9.1 Sunsmile Company Information
10.9.2 Sunsmile Introduction and Business Overview
10.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Sunsmile Antimicrobial Peptides Products Offered
10.9.5 Sunsmile Recent Development
10.10 Ruixing Biotechnology
10.10.1 Ruixing Biotechnology Company Information
10.10.2 Ruixing Biotechnology Introduction and Business Overview
10.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Ruixing Biotechnology Antimicrobial Peptides Products Offered
10.10.5 Ruixing Biotechnology Recent Development
10.11 Zhongnong Yingtai Biotechnology
10.11.1 Zhongnong Yingtai Biotechnology Company Information
10.11.2 Zhongnong Yingtai Biotechnology Introduction and Business Overview
10.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Products Offered
10.11.5 Zhongnong Yingtai Biotechnology Recent Development
10.12 Glam Technology
10.12.1 Glam Technology Company Information
10.12.2 Glam Technology Introduction and Business Overview
10.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Glam Technology Antimicrobial Peptides Products Offered
10.12.5 Glam Technology Recent Development
10.13 ProteLight Pharmaceutical & Biotechnology
10.13.1 ProteLight Pharmaceutical & Biotechnology Company Information
10.13.2 ProteLight Pharmaceutical & Biotechnology Introduction and Business Overview
10.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2024)
10.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Products Offered
10.13.5 ProteLight Pharmaceutical & Biotechnology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antimicrobial Peptides Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antimicrobial Peptides Industrial Chain Analysis
11.4 Antimicrobial Peptides Market Dynamics
11.4.1 Antimicrobial Peptides Industry Trends
11.4.2 Antimicrobial Peptides Market Drivers
11.4.3 Antimicrobial Peptides Market Challenges
11.4.4 Antimicrobial Peptides Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antimicrobial Peptides Distributors
12.3 Antimicrobial Peptides Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Plant Antimicrobial Peptides
Table 2. Major Company of Microbial Antimicrobial Peptides
Table 3. Major Company of Animal Antimicrobial Peptides
Table 4. Global Antimicrobial Peptides Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Antimicrobial Peptides Sales by Type (2018-2024) & (Mg)
Table 6. Global Antimicrobial Peptides Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Antimicrobial Peptides Sales by Type (2018-2024) & (US& Million)
Table 8. Global Antimicrobial Peptides Market Share in Value by Type (2018-2024)
Table 9. Global Antimicrobial Peptides Price by Type (2018-2024) & (US$/Mg)
Table 10. Global Antimicrobial Peptides Sales by Type (2024-2034) & (Mg)
Table 11. Global Antimicrobial Peptides Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Antimicrobial Peptides Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Antimicrobial Peptides Sales Market Share in Value by Type (2024-2034)
Table 14. Global Antimicrobial Peptides Price by Type (2024-2034) & (US$/Mg)
Table 15. North America Antimicrobial Peptides Sales by Type (2018-2024) & (Mg)
Table 16. North America Antimicrobial Peptides Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Antimicrobial Peptides Sales (Mg) by Type (2018-2024)
Table 18. Europe Antimicrobial Peptides Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Antimicrobial Peptides Sales (Mg) by Type (2018-2024)
Table 20. Asia-Pacific Antimicrobial Peptides Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Antimicrobial Peptides Sales (Mg) by Type (2018-2024)
Table 22. Latin America Antimicrobial Peptides Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Antimicrobial Peptides Sales (Mg) by Type (2018-2024)
Table 24. Middle East and Africa Antimicrobial Peptides Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Antimicrobial Peptides Sales by Company (2018-2024) & (Mg)
Table 26. Global Antimicrobial Peptides Sales Share by Company (2018-2024)
Table 27. Global Antimicrobial Peptides Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Antimicrobial Peptides Revenue Share by Company (2018-2024)
Table 29. Global Market Antimicrobial Peptides Price by Company (2018-2024) & (US$/Mg)
Table 30. Global Antimicrobial Peptides Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Antimicrobial Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2022)
Table 33. Date of Key Manufacturers Enter into Antimicrobial Peptides Market
Table 34. Key Manufacturers Antimicrobial Peptides Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Antimicrobial Peptides Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Antimicrobial Peptides Sales by Region (2018-2024) & (Mg)
Table 38. Global Antimicrobial Peptides Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Antimicrobial Peptides Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Antimicrobial Peptides Sales Market Share in Value by Region (2018-2024)
Table 41. Global Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2018-2024)
Table 42. Global Antimicrobial Peptides Sales by Region (2024-2034) & (Mg)
Table 43. Global Antimicrobial Peptides Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Antimicrobial Peptides Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Antimicrobial Peptides Sales Market Share in Value by Region (2024-2034)
Table 46. Global Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2024-2034)
Table 47. Global Antimicrobial Peptides Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Antimicrobial Peptides Sales by Application (2018-2024) & (Mg)
Table 49. Global Antimicrobial Peptides Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Antimicrobial Peptides Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Antimicrobial Peptides Sales Market Share in Value by Application (2018-2024)
Table 52. Global Antimicrobial Peptides Price by Application (2018-2024) & (US$/Mg)
Table 53. Global Antimicrobial Peptides Sales by Application (2024-2034) & (Mg)
Table 54. Global Antimicrobial Peptides Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Antimicrobial Peptides Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Antimicrobial Peptides Sales Market Share in Value by Application (2024-2034)
Table 57. Global Antimicrobial Peptides Price by Application (2024-2034) & (US$/Mg)
Table 58. North America Antimicrobial Peptides Sales by Application (2018-2024) (Mg)
Table 59. North America Antimicrobial Peptides Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Antimicrobial Peptides Sales by Application (2018-2024) (Mg)
Table 61. Europe Antimicrobial Peptides Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Antimicrobial Peptides Sales by Application (2018-2024) (Mg)
Table 63. Asia-Pacific Antimicrobial Peptides Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Antimicrobial Peptides Sales by Application (2018-2024) (Mg)
Table 65. Latin America Antimicrobial Peptides Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Antimicrobial Peptides Sales by Application (2018-2024) (Mg)
Table 67. Middle East and Africa Antimicrobial Peptides Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Antimicrobial Peptides Sales by Country (2018-2024) & (Mg)
Table 69. North America Antimicrobial Peptides Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Antimicrobial Peptides Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Antimicrobial Peptides Sales Market Share in Value by Country (2018-2024)
Table 72. North America Antimicrobial Peptides Sales by Country (2024-2034) & (Mg)
Table 73. North America Antimicrobial Peptides Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Antimicrobial Peptides Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Antimicrobial Peptides Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Antimicrobial Peptides Sales by Country (2018-2024) & (Mg)
Table 77. Europe Antimicrobial Peptides Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Antimicrobial Peptides Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Antimicrobial Peptides Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Antimicrobial Peptides Sales by Country (2024-2034) & (Mg)
Table 81. Europe Antimicrobial Peptides Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Antimicrobial Peptides Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Antimicrobial Peptides Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Antimicrobial Peptides Sales by Region (2018-2024) & (Mg)
Table 85. Asia-Pacific Antimicrobial Peptides Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Antimicrobial Peptides Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Antimicrobial Peptides Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Antimicrobial Peptides Sales by Region (2024-2034) & (Mg)
Table 89. Asia-Pacific Antimicrobial Peptides Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Antimicrobial Peptides Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Antimicrobial Peptides Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Antimicrobial Peptides Sales by Country (2018-2024) & (Mg)
Table 93. Latin America Antimicrobial Peptides Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Antimicrobial Peptides Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Antimicrobial Peptides Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Antimicrobial Peptides Sales by Country (2024-2034) & (Mg)
Table 97. Latin America Antimicrobial Peptides Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Antimicrobial Peptides Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Antimicrobial Peptides Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Antimicrobial Peptides Sales by Country (2018-2024) & (Mg)
Table 101. Middle East and Africa Antimicrobial Peptides Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Antimicrobial Peptides Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Antimicrobial Peptides Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Antimicrobial Peptides Sales by Country (2024-2034) & (Mg)
Table 105. Middle East and Africa Antimicrobial Peptides Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Antimicrobial Peptides Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Antimicrobial Peptides Sales Market Share in Value by Country (2024-2034)
Table 108. AnaSpec Company Information
Table 109. AnaSpec Introduction and Business Overview
Table 110. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2024)
Table 111. AnaSpec Antimicrobial Peptides Product
Table 112. AnaSpec Recent Development
Table 113. AMP Biotech Company Information
Table 114. AMP Biotech Introduction and Business Overview
Table 115. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2024)
Table 116. AMP Biotech Antimicrobial Peptides Product
Table 117. AMP Biotech Recent Development
Table 118. Phoenix Biotech Company Information
Table 119. Phoenix Biotech Introduction and Business Overview
Table 120. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2024)
Table 121. Phoenix Biotech Antimicrobial Peptides Product
Table 122. Phoenix Biotech Recent Development
Table 123. Novabiotics Company Information
Table 124. Novabiotics Introduction and Business Overview
Table 125. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2024)
Table 126. Novabiotics Antimicrobial Peptides Product
Table 127. Novabiotics Recent Development
Table 128. Chinese Peptide Company Information
Table 129. Chinese Peptide Introduction and Business Overview
Table 130. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2024)
Table 131. Chinese Peptide Antimicrobial Peptides Product
Table 132. Chinese Peptide Recent Development
Table 133. Ontores Company Information
Table 134. Ontores Introduction and Business Overview
Table 135. Ontores Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2024)
Table 136. Ontores Antimicrobial Peptides Product
Table 137. Ontores Recent Development
Table 138. GenScript Company Information
Table 139. GenScript Introduction and Business Overview
Table 140. GenScript Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2024)
Table 141. GenScript Antimicrobial Peptides Product
Table 142. GenScript Recent Development
Table 143. Hycult Biotech Company Information
Table 144. Hycult Biotech Introduction and Business Overview
Table 145. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2024)
Table 146. Hycult Biotech Antimicrobial Peptides Product
Table 147. Hycult Biotech Recent Development
Table 148. Sunsmile Company Information
Table 149. Sunsmile Introduction and Business Overview
Table 150. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2024)
Table 151. Sunsmile Antimicrobial Peptides Product
Table 152. Sunsmile Recent Development
Table 153. Ruixing Biotechnology Company Information
Table 154. Ruixing Biotechnology Introduction and Business Overview
Table 155. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2024)
Table 156. Ruixing Biotechnology Antimicrobial Peptides Product
Table 157. Ruixing Biotechnology Recent Development
Table 158. Zhongnong Yingtai Biotechnology Company Information
Table 159. Zhongnong Yingtai Biotechnology Introduction and Business Overview
Table 160. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2024)
Table 161. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product
Table 162. Zhongnong Yingtai Biotechnology Recent Development
Table 163. Glam Technology Company Information
Table 164. Glam Technology Introduction and Business Overview
Table 165. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2024)
Table 166. Glam Technology Antimicrobial Peptides Product
Table 167. Glam Technology Recent Development
Table 168. ProteLight Pharmaceutical & Biotechnology Company Information
Table 169. ProteLight Pharmaceutical & Biotechnology Introduction and Business Overview
Table 170. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2024)
Table 171. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product
Table 172. ProteLight Pharmaceutical & Biotechnology Recent Development
Table 173. Key Raw Materials Lists
Table 174. Raw Materials Key Suppliers Lists
Table 175. Antimicrobial Peptides Market Trends
Table 176. Antimicrobial Peptides Market Drivers
Table 177. Antimicrobial Peptides Market Challenges
Table 178. Antimicrobial Peptides Market Restraints
Table 179. Antimicrobial Peptides Distributors List
Table 180. Antimicrobial Peptides Downstream Customers
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Antimicrobial Peptides Product Picture
Figure 2. Global Antimicrobial Peptides Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Antimicrobial Peptides Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Antimicrobial Peptides Sales Status and Outlook (2018-2034) & (Mg)
Figure 5. Product Picture of Plant Antimicrobial Peptides
Figure 6. Global Plant Antimicrobial Peptides Sales YoY Growth (2018-2034) & (Mg)
Figure 7. Product Picture of Microbial Antimicrobial Peptides
Figure 8. Global Microbial Antimicrobial Peptides Sales YoY Growth (2018-2034) & (Mg)
Figure 9. Product Picture of Animal Antimicrobial Peptides
Figure 10. Global Animal Antimicrobial Peptides Sales YoY Growth (2018-2034) & (Mg)
Figure 11. Global Antimicrobial Peptides Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Antimicrobial Peptides Sales Market Share by Type in 2022 & 2034
Figure 13. North America Antimicrobial Peptides Sales Market Share in Volume by Type in 2022
Figure 14. North America Antimicrobial Peptides Sales Market Share in Value by Type in 2022
Figure 15. Europe Antimicrobial Peptides Sales Market Share in Volume by Type in 2022
Figure 16. Europe Antimicrobial Peptides Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Antimicrobial Peptides Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Antimicrobial Peptides Sales Market Share in Value by Type in 2022
Figure 19. Latin America Antimicrobial Peptides Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Antimicrobial Peptides Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Antimicrobial Peptides Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Antimicrobial Peptides Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Antimicrobial Peptides Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Antimicrobial Peptides Revenue in 2022
Figure 25. Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Pharmaceuticals
Figure 27. Global Pharmaceuticals Sales YoY Growth (2018-2034) & (Mg)
Figure 28. Product Picture of Feed Additives
Figure 29. Global Feed Additives Sales YoY Growth (2018-2034) & (Mg)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2034) & (Mg)
Figure 32. Global Antimicrobial Peptides Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Antimicrobial Peptides Sales Market Share by Application in 2022 & 2034
Figure 34. North America Antimicrobial Peptides Sales Market Share in Volume by Application in 2022
Figure 35. North America Antimicrobial Peptides Sales Market Share in Value by Application in 2022
Figure 36. Europe Antimicrobial Peptides Sales Market Share in Volume by Application in 2022
Figure 37. Europe Antimicrobial Peptides Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Antimicrobial Peptides Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Antimicrobial Peptides Sales Market Share in Value by Application in 2022
Figure 40. Latin America Antimicrobial Peptides Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Antimicrobial Peptides Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Antimicrobial Peptides Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Antimicrobial Peptides Manufacturing Cost Structure
Figure 45. Antimicrobial Peptides Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries